million. Q4/2018, the Company and its subsidiary had independent specialist to evaluate and reclassified employee benefit payables as well as recognised actuarial loss Baht 0.44 million deductible deferred

Expenses The income tax expense of the Group in 3Q2019 was THB 79. 30 million, increased by THB 14. 91 million or 23.15% up from 3Q2018 mainly from higher deferred tax expenses. Income tax expense for 9M2019

Change THB Mn THB Mn THB Mn %QoQ %YoY THB Mn THB Mn %YoY Tax income (expense) (1.1) 14.6 (9.0) N.A. (

% . This is because in 2023, the Company's income tax expenses increased significantly since the Company did not record allowances for expected credit losses from related receivables as deferred tax assets

Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain

Securities and Exchange Commission concerning Rules Relating to Maintaining of Capital Adequacy and Professional Indemnity Insurance of Management Companies; (2) the management company is not being

Notification of the Securities and Exchange Commission concerning Rules Relating to Maintaining of Capital Adequacy and Professional Indemnity Insurance of Management Companies; (2) the management company is not

deferred remunerations and benefits accrued for the year, even if they are payable at a later date. In the case where the remunerations in the previous year do not reflect the actual remunerations (for

last year. Financing cost to revenue ratio was 10.9%, closed to the same period of last year which was 10. 1%. However, MK still focused on maintaining its interest- bearing debt to equity ratio in an

proportion of house brand product sales compared to previous period. The Company has focus in maintaining gross profit margin, emphasizing FN brand awareness and increasing FN brand equity, so the marketing